BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 3018739)

  • 1. Antitumor effects of an immunotoxin made with Pseudomonas exotoxin in a nude mouse model of human ovarian cancer.
    FitzGerald DJ; Willingham MC; Pastan I
    Proc Natl Acad Sci U S A; 1986 Sep; 83(17):6627-30. PubMed ID: 3018739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monovalent immunotoxin containing truncated form of Pseudomonas exotoxin as potent antitumor agent.
    Debinski W; Pastan I
    Cancer Res; 1992 Oct; 52(19):5379-85. PubMed ID: 1394141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemoimmunotoxin therapy against a human colon tumor (HT-29) xenografted into nude mice.
    Pearson JW; FitzGerald DJ; Willingham MC; Wiltrout RH; Pastan I; Longo DL
    Cancer Res; 1989 Jul; 49(13):3562-7. PubMed ID: 2499420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced therapeutic efficacy against an ovarian tumor xenograft of immunotoxins used in conjunction with recombinant alpha-interferon.
    Pearson JW; Hedrick E; Fogler WE; Bull RL; Ferris DK; Riggs CW; Wiltrout RH; Sivam G; Morgan AC; Groves E
    Cancer Res; 1990 Oct; 50(19):6379-88. PubMed ID: 2144790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced therapeutic efficacy of an immunotoxin in combination with chemotherapy against an intraperitoneal human tumor xenograft in athymic mice.
    Pearson JW; Sivam G; Manger R; Wiltrout RH; Morgan AC; Longo DL
    Cancer Res; 1989 Sep; 49(18):4990-5. PubMed ID: 2504482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pseudomonas exotoxin coupled to a monoclonal antibody against ovarian cancer inhibits the growth of human ovarian cancer cells in a mouse model.
    Willingham MC; FitzGerald DJ; Pastan I
    Proc Natl Acad Sci U S A; 1987 Apr; 84(8):2474-8. PubMed ID: 3104916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical evaluation of intraperitoneal Pseudomonas exotoxin immunoconjugate OVB3-PE in patients with ovarian cancer.
    Pai LH; Bookman MA; Ozols RF; Young RC; Smith JW; Longo DL; Gould B; Frankel A; McClay EF; Howell S
    J Clin Oncol; 1991 Dec; 9(12):2095-103. PubMed ID: 1960550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-transferrin receptor antibody linked to Pseudomonas exotoxin as a model immunotoxin in human ovarian carcinoma cell lines.
    Pirker R; FitzGerald DJ; Hamilton TC; Ozols RF; Willingham MC; Pastan I
    Cancer Res; 1985 Feb; 45(2):751-7. PubMed ID: 2981613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-tumor activity of K1-LysPE38QQR, an immunotoxin targeting mesothelin, a cell-surface antigen overexpressed in ovarian cancer and malignant mesothelioma.
    Hassan R; Viner JL; Wang QC; Margulies I; Kreitman RJ; Pastan I
    J Immunother; 2000; 23(4):473-9. PubMed ID: 10916757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-tumor activities of immunotoxins made of monoclonal antibody B3 and various forms of Pseudomonas exotoxin.
    Pai LH; Batra JK; FitzGerald DJ; Willingham MC; Pastan I
    Proc Natl Acad Sci U S A; 1991 Apr; 88(8):3358-62. PubMed ID: 2014255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor activity in mice of an immunotoxin made with anti-transferrin receptor and a recombinant form of Pseudomonas exotoxin.
    Batra JK; Jinno Y; Chaudhary VK; Kondo T; Willingham MC; FitzGerald DJ; Pastan I
    Proc Natl Acad Sci U S A; 1989 Nov; 86(21):8545-9. PubMed ID: 2510169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor effects of B3-PE and B3-LysPE40 in a nude mouse model of human breast cancer and the evaluation of B3-PE toxicity in monkeys.
    Pai LH; Batra JK; FitzGerald DJ; Willingham MC; Pastan I
    Cancer Res; 1992 Jun; 52(11):3189-93. PubMed ID: 1591729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibody C242-Pseudomonas exotoxin A. A specific and potent immunotoxin with antitumor activity on a human colon cancer xenograft in nude mice.
    Debinski W; Karlsson B; Lindholm L; Siegall CB; Willingham MC; FitzGerald D; Pastan I
    J Clin Invest; 1992 Aug; 90(2):405-11. PubMed ID: 1644913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of compartmental administration of immunotoxin LMB-1 (B3-LysPE38) in a rat model of carcinomatous meningitis.
    Bigner DD; Archer GE; McLendon RE; Friedman HS; Fuchs HE; Pai LH; Herndon JE; Pastan IH
    Clin Cancer Res; 1995 Dec; 1(12):1545-55. PubMed ID: 9815955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxic and antitumor activity of a recombinant immunotoxin composed of disulfide-stabilized anti-Tac Fv fragment and truncated Pseudomonas exotoxin.
    Reiter Y; Kreitman RJ; Brinkmann U; Pastan I
    Int J Cancer; 1994 Jul; 58(1):142-9. PubMed ID: 8014011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting tumor-associated macrophages in an experimental glioma model with a recombinant immunotoxin to folate receptor beta.
    Nagai T; Tanaka M; Tsuneyoshi Y; Xu B; Michie SA; Hasui K; Hirano H; Arita K; Matsuyama T
    Cancer Immunol Immunother; 2009 Oct; 58(10):1577-86. PubMed ID: 19238383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant single-chain and disulfide-stabilized Fv-immunotoxins that cause complete regression of a human colon cancer xenograft in nude mice.
    Reiter Y; Wright AF; Tonge DW; Pastan I
    Int J Cancer; 1996 Jul; 67(1):113-23. PubMed ID: 8690511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic interaction between an anti-p185HER-2 pseudomonas exotoxin fusion protein [scFv(FRP5)-ETA] and ionizing radiation for inhibiting growth of ovarian cancer cells that overexpress HER-2.
    Schmidt M; McWatters A; White RA; Groner B; Wels W; Fan Z; Bast RC
    Gynecol Oncol; 2001 Feb; 80(2):145-55. PubMed ID: 11161852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Administration of disulfide-stabilized Fv-immunotoxins B1(dsFv)-PE38 and B3(dsFv)-PE38 by continuous infusion increases their efficacy in curing large tumor xenografts in nude mice.
    Benhar I; Reiter Y; Pai LH; Pastan I
    Int J Cancer; 1995 Jul; 62(3):351-5. PubMed ID: 7628878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-Tac(Fab)-PE40, a recombinant double-chain immunotoxin which kills interleukin-2-receptor-bearing cells and induces complete remission in an in vivo tumor model.
    Kreitman RJ; Chang CN; Hudson DV; Queen C; Bailon P; Pastan I
    Int J Cancer; 1994 Jun; 57(6):856-64. PubMed ID: 8206679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.